Antibody Quantitation via IdeS Digestion and Native SCX-MS

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for characterizing and quantifying therapeutic peptides or proteins, such as antibodies, face challenges due to post-translational modifications, protein degradation, and chemical modifications during production and purification, which affect their safety, efficacy, and shelf life, especially in complex matrices like serum, requiring high-throughput and high-sensitivity techniques.

Innovation Solution

A native SCX-MS method involving immunoprecipitation with agarose beads and digestion by IdeS enzyme to produce Fab2 fragments, followed by native SCX-MS analysis, enabling sensitive and robust quantitation of antibodies even at low concentrations in neat solutions or serum.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional detection methods are used for therapeutic peptides or proteins in complex matrices like serum, then the analysis can be performed with standard equipment, but the sensitivity and specificity are insufficient to accurately detect low concentrations of antibodies

Engineering Contradiction:
Improvedetection sensitivityVSAvoidanalysis method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The antibody molecule is divided into Fab2 fragments through enzymatic digestion with IdeS. This segmentation reduces the molecular complexity and increases the surface-area-to-volume ratio, enhancing ionization efficiency and detection sensitivity in native SCX-MS analysis while maintaining the ability to detect low concentrations in complex matrices

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Immunoprecipitation using anti-Fc antibody-coated beads serves as an intermediary step to selectively capture and concentrate antibodies from complex serum matrices before digestion and MS analysis. This intermediary purification step removes matrix interference and enriches the target analyte, enabling sensitive detection without requiring overly complex direct analysis methods

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If immunoprecipitation with anti-Fc antibody beads is used to capture antibodies from serum, then antibodies can be selectively enriched, but the process requires additional steps and time

Engineering Contradiction:
Improvequantitation accuracyVSAvoidanalysis time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The method merges multiple functions into a streamlined workflow: immunoprecipitation captures antibodies while simultaneously concentrating them from serum; subsequent IdeS digestion releases Fab2 fragments that are directly compatible with native SCX-MS analysis. This merging of enrichment, digestion, and analysis preparation steps into a sequential protocol improves reliability while managing time efficiency through optimized step transitions

Inventive Principle:
Principle #5Merging (Combining)

3Measurement precision

If native SCX-MS analysis is performed on intact antibodies, then the analysis can be done without extensive sample preparation, but the sensitivity is insufficient for low concentration samples in complex matrices

Engineering Contradiction:
Improvequantitation sensitivityVSAvoidsample preparation simplicity
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

Preliminary immunoprecipitation is performed to capture and concentrate antibodies from serum before digestion and MS analysis. This preliminary enrichment action ensures sufficient analyte concentration is achieved before the actual native SCX-MS measurement, enabling sensitive detection of low concentration samples while maintaining relative simplicity in the overall workflow

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method efficiently and accurately quantitates antibodies with a low limit of detection and quantitation, effectively separating antibodies from matrix proteins, demonstrating superior sensitivity and specificity, particularly in complex biological samples like serum.

Implementation Method 1

Immunoprecipitation with agarose beads coated in anti-human Fc antibody may be used to pull down a human antibody in a sample

Methodology Applied
Scientific EffectImmunoprecipitation: Adsorption

Implementation Method 2

The digestive enzyme IdeS or a variant thereof may be used to cleave the immobilized antibody, producing a Fab2 fragment

Methodology Applied
Scientific EffectEnzymatic digestion: Enzyme

Implementation Method 3

subjecting said eluate to native SCX-MS analysis

Methodology Applied
Scientific EffectStrong cation exchange chromatography: Ion Exchange

Implementation Method 4

native SCX-MS analysis for sensitive and robust quantitation

Methodology Applied
Scientific EffectMass spectrometry detection:

Data Source

PatentUS20230017454A1Bioanalysis of therapeutic antibodies and related products using immunoprecipitation and native SCX-ms detection
Publication Date: 2023.01.19 REGENERON PHARMACEUTICALS INC
  • US20230017454A1 patent drawing
  • US20230017454A1 patent drawing
  • US20230017454A1 patent drawing

AI summary

The present invention generally pertains to methods of characterizing antibodies and related products. In particular, the present invention pertains to the use of immunoprecipitation and native strong cation exchange chromatography-mass spectrometry to specifically and sensitively detected and quantitate antibodies and related products in a sample.